General Information of Drug (ID: DMUMOEV)

Drug Name
Ansuvimab Drug Info
Indication
Disease Entry ICD 11 Status REF
Ebola virus infection 1D60.0 Approved [1]
Cross-matching ID
TTD Drug ID
DMUMOEV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MAb114 DM948AP Ebola virus infection 1D60.0 Phase 2/3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ebola virus Envelope glycoprotein (EV GP) TT2F0AU VGP_EBOZM Not Available [1]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2 Ansuvimab: First Approval. Drugs. 2021 Apr;81(5):595-598.